Biogen Idec Inc. (BIIB) gapped open sharply lower Wednesday, following a downgrade by Citigroup to "Neutral" from "Buy." The stock has since moved in a narrow range.
Biogen Idec has dropped in the last 15 minutes on increased volume and is now down 10.82 at $212.21. The stock is testing the lower end of a week and a half long range.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.